Blonder Tongue Laboratories
Blonder Tongue Laboratories
BDRL
OTC
0.06
USD
0.00%
About
Blonder Tongue Laboratories, Inc., along with its subsidiary R. L. Drake Holdings, LLC (Drake), is a technology research and development company. The Company delivers a range of products and services to telecommunications, cable and fiber optic service delivery operators, as well as broadcasters and media production companies.
Its products are deployed in a list of locations, including lodging/hospitality, multi-dwelling units/apartments, broadcast studios/networks, universities/schools, healthcare/hospitals, fitness centers, government facilities/offices, prisons, airports, sports stadiums/arenas, entertainment venues/casinos, retail stores, and small-medium businesses.
The Company’s products are divided into five categories: Encoders and Transcoders, NeXgen Gateway (NXG), Coax Distribution, consumer premise equipment (CPE) and Digital Modulation. Its Encoder/Transcoder Products are used by a system operator for encoding and transcoding of digital video..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 1.7K |
| Three Month Average Volume | 70.7K |
| High Low | |
| Fifty-Two Week High | 0.265 USD |
| Fifty-Two Week Low | 0.0601 USD |
| Fifty-Two Week High Date | 16 Nov 2023 |
| Fifty-Two Week Low Date | 24 Oct 2023 |
| Price and Volume | |
| Current Price | 0.0878 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 35.80% |
| Thirteen Week Relative Price Change | -18.78% |
| Twenty-Six Week Relative Price Change | -42.96% |
| Fifty-Two Week Relative Price Change | -46.10% |
| Year-to-Date Relative Price Change | -9.03% |
| Price Change | |
| One Day Price Change | 23.66% |
| Thirteen Week Price Change | -13.07% |
| Twenty-Six Week Price Change | -37.29% |
| Five Day Price Change | -1.82% |
| Fifty-Two Week Price Change | -32.46% |
| Year-to-Date Price Change | 7.73% |
| Month-to-Date Price Change | 9.82% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | -0.03639 USD |
| Book Value Per Share (Most Recent Quarter) | 0.08046 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | -0.1223 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | -0.01221 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.15112 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.94426 USD |
| Revenue Per Share (Trailing Twelve Months) | 1.364 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.15129 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.22057 USD |
| Normalized (Last Fiscal Year) | -0.15129 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.15129 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.22057 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.15129 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.22057 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.00056 USD |
| Cash Per Share (Most Recent Quarter) | 0.00592 USD |
| Cash Flow Per Share (Last Fiscal Year) | -0.14522 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.21053 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.1082 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -14 |
| Cash Flow Revenue (Trailing Twelve Months) | -8 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -16.12% |
| Pretax Margin (Last Fiscal Year) | -15.93% |
| Pretax Margin (5 Year) | -15.74% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 30.11% |
| Gross Margin (Trailing Twelve Months) | 30.16% |
| Gross Margin (5 Year) | 26.11% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -9.52% |
| Operating Margin (Trailing Twelve Months) | -11.77% |
| Operating Margin (5 Year) | -23.21% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -16.02% |
| Net Profit Margin (Trailing Twelve Months) | -16.12% |
| Net Profit Margin (5 Year) | -15.81% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 22.52% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 32.18% |
| Revenue Growth (3 Year) | -9.45% |
| Revenue Change (Trailing Twelve Months) | 14.99% |
| Revenue Per Share Growth | -17.29% |
| Revenue Growth (5 Year) | -6.91% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 44.98% |
| Total Debt (5 Year) | -2.43% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 109.26% |
| EPS Change (Trailing Twelve Months) | -1,113.26% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | -100,000 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 1 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 6.1M |
| Net Debt (Last Fiscal Year) | 5.2M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 3 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 2 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | -100,000 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | -100,000 |
| Long Term Debt to Equity (Most Recent Quarter) | 157 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 0 |
| Quick Ratio (Most Recent Quarter) | 0 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 1.3M |
| Free Cash Flow (Trailing Twelve Months) | -1,437,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -1 |
| Net Interest Coverage (Trailing Twelve Months) | -3 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | -100,000 |
| Total Debt to Equity (Most Recent Quarter) | 572 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -16.07% |
| Return on Assets (Trailing Twelve Months) | -21.71% |
| Return on Assets (5 Year) | -18.85% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -769.82% |
| Return on Equity (Trailing Twelve Months) | -134.02% |
| Return on Equity (5 Year) | -80.89% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -35.94% |
| Return on Investment (Trailing Twelve Months) | -46.00% |
| Return on Investment (5 Year) | -38.27% |